Dizal (jiangsu) Pharmaceutical Co. Ltd. Class ASSE: 688192

2025 Annual Report

Mar 31, 2026 · Issued by Dizal (jiangsu) Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange

2025 Annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment